Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia
| Image |  |
|---|---|
| Description | scientific article published on 10 November 2014 |
| Author/s |
author: Albrecht Reichle Gerhard Zugmaier Hermann Einsele Monika Brüggemann Dieter Hoelzer Nicola Gökbuget |
| Publication date | November 10, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |